Sweden’s benchmark equity index closed higher on Tuesday, with the OMX Stockholm 30 gaining 0.83% as gains in healthcare, telecoms and industrials offset declines in defense and consumer goods.
Advancing issues outnumbered decliners by 488 to 249 on the Stockholm Stock Exchange, with 70 stocks unchanged. The index’s rise followed modest weakness in broader European equities and a pullback in crude oil prices.
AstraZeneca led advances in the index, rising 2.61% to 1,609.00 points, while Sandvik added 1.99% to 394.80. Alfa Laval climbed 1.59% to 575.00. Among the laggards, SAAB fell 0.62% to 638.20, Svenska Cellulosa dipped 0.22% to 112.00, and Essity declined 0.18% to 280.70.
Commodities showed mixed performance. October crude oil futures fell 3.34% to $82.17 per barrel, while November Brent crude declined 3.41% to $87.45. December gold futures rose 0.13% to $4,703.96 per troy ounce.
The Swedish krona weakened modestly against major currencies, with EUR/SEK down 0.14% to 11.05 and USD/SEK falling 0.22% to 9.47. The U.S. Dollar Index futures were down 0.05% at 98.88.
